Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Recent Progress in European Advanced Therapy Medicinal Products and Beyond.

Yu TTL, Gupta P, Ronfard V, Vertès AA, Bayon Y.

Front Bioeng Biotechnol. 2018 Sep 21;6:130. doi: 10.3389/fbioe.2018.00130. eCollection 2018.

2.

How Regenerative Medicine Stakeholders Adapt to Ever-Changing Technology and Regulatory Challenges? Snapshots from the World TERMIS Industry Symposium (September 10, 2015, Boston).

Bayon Y, Van Dyke M, Buelher R, Tubo R, Bertram T, Malfroy-Camine B, Rathman M, Ronfard V.

Tissue Eng Part B Rev. 2017 Apr;23(2):159-162. doi: 10.1089/ten.TEB.2016.0292. Epub 2016 Nov 21.

PMID:
27771996
3.

Evaluating the Past, Present, and Future of Regenerative Medicine: A Global View.

Ronfard V, Vertès AA, May MH, Dupraz A, van Dyke ME, Bayon Y.

Tissue Eng Part B Rev. 2017 Apr;23(2):199-210. doi: 10.1089/ten.TEB.2016.0291. Epub 2016 Nov 21. Review.

PMID:
27762892
4.

Identification and Characterization of Novel Matrix-Derived Bioactive Peptides: A Role for Collagenase from Santyl® Ointment in Post-Debridement Wound Healing?

Sheets AR, Demidova-Rice TN, Shi L, Ronfard V, Grover KV, Herman IM.

PLoS One. 2016 Jul 26;11(7):e0159598. doi: 10.1371/journal.pone.0159598. eCollection 2016.

5.

Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products.

Bayon Y, Vertès AA, Ronfard V, Culme-Seymour E, Mason C, Stroemer P, Najimi M, Sokal E, Wilson C, Barone J, Aras R, Chiesi A.

Tissue Eng Part B Rev. 2015 Dec;21(6):560-71. doi: 10.1089/ten.TEB.2015.0068. Epub 2015 Aug 27. Review.

PMID:
26179129
6.

Translating cell-based regenerative medicines from research to successful products: challenges and solutions.

Bayon Y, Vertès AA, Ronfard V, Egloff M, Snykers S, Salinas GF, Thomas R, Girling A, Lilford R, Clermont G, Kemp P.

Tissue Eng Part B Rev. 2014 Aug;20(4):246-56. doi: 10.1089/ten.TEB.2013.0727. Epub 2014 Jun 12.

PMID:
24754565
7.

Biochemical and biomechanical characterization of porcine small intestinal submucosa (SIS): a mini review.

Shi L, Ronfard V.

Int J Burns Trauma. 2013 Nov 1;3(4):173-9. eCollection 2013. Review.

8.

Epidermal stem cells are preserved during commercial-scale manufacture of a bilayered, living cellular construct (Apligraf®).

Carlson M, Faria K, Shamis Y, Leman J, Ronfard V, Garlick J.

Tissue Eng Part A. 2011 Feb;17(3-4):487-93. doi: 10.1089/ten.TEA.2010.0268. Epub 2010 Nov 1.

PMID:
20849380
9.

De novo synthesis of human dermis in vitro in the absence of a three-dimensional scaffold.

Pouyani T, Ronfard V, Scott PG, Dodd CM, Ahmed A, Gallo RL, Parenteau NL.

In Vitro Cell Dev Biol Anim. 2009 Sep;45(8):430-41. doi: 10.1007/s11626-009-9213-6. Epub 2009 Jun 16.

PMID:
19533257
11.
12.

Migration of keratinocytes through tunnels of digested fibrin.

Ronfard V, Barrandon Y.

Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4504-9. Epub 2001 Mar 27.

13.

Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix.

Ronfard V, Rives JM, Neveux Y, Carsin H, Barrandon Y.

Transplantation. 2000 Dec 15;70(11):1588-98.

PMID:
11152220
14.
15.

Use of human keratinocytes cultured on fibrin glue in the treatment of burn wounds.

Ronfard V, Broly H, Mitchell V, Galizia JP, Hochart D, Chambon E, Pellerin P, Huart JJ.

Burns. 1991 Jun;17(3):181-4.

PMID:
1892546

Supplemental Content

Loading ...
Support Center